Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015 Released On 16th March 2015
Summary Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015, provides an overview of the Diabetic Peripheral Neuropathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Peripheral Neuropathy and special features on late-stage and discontinued projects. JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global therapeutic landscape of Diabetic Peripheral Neuropathy The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Diabetic Peripheral Neuropathy and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Diabetic Peripheral Neuropathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Diabetic Peripheral Neuropathy pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Browse complete Report on: http://www.jsbmarketresearch.com/healthcare-medical/r-diabetic-peripheralneuropathy-pipeline-review-h1-2015-162819
Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Diabetic Peripheral Neuropathy Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Diabetic Peripheral Neuropathy pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Introduction 5 Global Markets Direct Report Coverage 5 Diabetic Peripheral Neuropathy Overview 6 Therapeutics Development 7 Pipeline Products for Diabetic Peripheral Neuropathy - Overview 7 Pipeline Products for Diabetic Peripheral Neuropathy - Comparative Analysis 8 Diabetic Peripheral Neuropathy - Therapeutics under Development by Companies 9 Diabetic Peripheral Neuropathy - Therapeutics under Investigation by Universities/Institutes 10 Diabetic Peripheral Neuropathy - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Diabetic Peripheral Neuropathy - Products under Development by Companies 13 Diabetic Peripheral Neuropathy - Products under Investigation by Universities/Institutes 14 Diabetic Peripheral Neuropathy - Companies Involved in Therapeutics Development 15 Astellas Pharma Inc. 15 BioChemics, Inc. 16 Cebix Incorporated 17 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Pfizer Inc. 18 ViroMed Co., Ltd. 19 Diabetic Peripheral Neuropathy - Therapeutics Assessment 20 Assessment by Monotherapy Products 20 Assessment by Target 21 Assessment by Mechanism of Action 23 Assessment by Route of Administration 25 Assessment by Molecule Type 27 Drug Profiles 29 Antimunocel - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 ASP-8477 - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 benfotiamine - Drug Profile 31 Product Description 31 Mechanism of Action 31 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress 31 CBX-129801 - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 CNV-2197944 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 epalrestat - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 PF-05089771 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 Small Molecules for Peripheral Neuropathy and Amyotrophic Lateral Sclerosis - Drug Profile 40 Product Description 40 Mechanism of Action 40 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
R&D Progress 40 VM-202 - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 Diabetic Peripheral Neuropathy - Recent Pipeline Updates 43 Diabetic Peripheral Neuropathy - Dormant Projects 46 Diabetic Peripheral Neuropathy - Discontinued Products 47 Diabetic Peripheral Neuropathy - Product Development Milestones 48 Featured News & Press Releases 48 Jun 09, 2012: Cebixs Ersatta Demonstrates Encouraging Results In Phase I Study Of Diabetic Peripheral Neuropathy 48 Appendix 49 Methodology 49 Coverage 49 Secondary Research 49 Primary Research 49 Expert Panel Validation 49 Contact Us 50 Disclaimer 50
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
List Of Tables Number of Products under Development for Diabetic Peripheral Neuropathy, H1 2015 7 Number of Products under Development for Diabetic Peripheral Neuropathy - Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Number of Products under Investigation by Universities/Institutes, H1 2015 10 Comparative Analysis by Clinical Stage Development, H1 2015 11 Comparative Analysis by Early Stage Development, H1 2015 12 Products under Development by Companies, H1 2015 13 Products under Investigation by Universities/Institutes, H1 2015 14 Diabetic Peripheral Neuropathy - Pipeline by Astellas Pharma Inc., H1 2015 15 Diabetic Peripheral Neuropathy - Pipeline by BioChemics, Inc., H1 2015 16 Diabetic Peripheral Neuropathy - Pipeline by Cebix Incorporated, H1 2015 17 Diabetic Peripheral Neuropathy - Pipeline by Pfizer Inc., H1 2015 18 Diabetic Peripheral Neuropathy - Pipeline by ViroMed Co., Ltd., H1 2015 19 Assessment by Monotherapy Products, H1 2015 20 Number of Products by Stage and Target, H1 2015 22 Number of Products by Stage and Mechanism of Action, H1 2015 24 Number of Products by Stage and Route of Administration, H1 2015 26 Number of Products by Stage and Molecule Type, H1 2015 28 Diabetic Peripheral Neuropathy Therapeutics - Recent Pipeline Updates, H1 2015 43 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Diabetic Peripheral Neuropathy - Dormant Projects, H1 2015 46 Diabetic Peripheral Neuropathy - Discontinued Products, H1 2015 47 List Of Figures Number of Products under Development for Diabetic Peripheral Neuropathy, H1 2015 7 Number of Products under Development for Diabetic Peripheral Neuropathy - Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Comparative Analysis by Clinical Stage Development, H1 2015 11 Comparative Analysis by Early Stage Products, H1 2015 12 Assessment by Monotherapy Products, H1 2015 20 Number of Products by Top 10 Targets, H1 2015 21 Number of Products by Stage and Top 10 Targets, H1 2015 22 Number of Products by Top 10 Mechanism of Actions, H1 2015 23 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 24 Number of Products by Top 10 Routes of Administration, H1 2015 25 Number of Products by Stage and Top 10 Routes of Administration, H1 2015 26 Number of Products by Top 10 Molecule Types, H1 2015 27 Number of Products by Stage and Top 10 Molecule Types, H1 2015 28
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Product Price : License Type
Price
$ 2000
Site Licence
$ 4000
Enterprise Wide Licence
$ 6000
Related reports: Global HER-2 Positive Breast Cancer Market 2015-2019 Global Multiparameter Patient Monitoring Equipment Market 2015-2019 Healthcare IT Market in the US 2015-2019 Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019 Patient Monitoring and Diagnostic Systems Markets in China Hearing Aids Markets in China Medical Imaging System and Equipment Markets in China Medical Devices Markets in China Pharmaceutical Industry Business Confidence Report H1 2015 Healthcare and Medical Market Research JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stopshop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on “Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015� http://www.jsbmarketresearch.com/healthcare-medical/r-diabetic-peripheral-neuropathypipeline-review-h1-2015-162819
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/